Castle Creek Biosciences Expands its Innovative Gene Therapy Platform for Rare Genetic Connective Tissue Disorders through Research Collaboration with Mayo ClinicSeptember 29th, 2021|Cell and Gene Therapy, Innovation, Regional News Roundup|0 Comments Castle Creek Biosciences, Inc. announces research collaboration with Mayo Clinic.Article from PR NewswireShare This Story, Choose Your PlatformFacebookTwitterLinkedInPinterestEmail Related Posts Stories From Our Region – November 2022 HHS Secretary Becerra Joins U.S. Senator Casey for Visit with Leaders in Greater Philadelphia’s Life Sciences Ecosystem Stories From Our Region – October 2022 “Why Greater Philadelphia Ranks #2 As CGT Hub” Featured in Cell & Gene Stories From Our Region – Late September 2022 Leave A Comment Cancel replyComment Save my name, email, and website in this browser for the next time I comment. Current ye@r * Leave this field empty
Leave A Comment